Market Indices
Sector Heatmap
XTEN — BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
NYSE ArcaBondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
- O
- 42.11
- H
- 42.41
- L
- 42.06
- V
- 713.04K
XTEN — Latest News & Headlines
8 Stories(XTEN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
(XTEN) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily
FDA grants experimental prostate cancer drug a designation meant to speed review. Phase 3 trials are expected in 2027. - Stock Titan
FDA grants experimental prostate cancer drug a designation meant to speed review. Phase 3 trials are expected in 2027. Stock Titan
Vir Biotechnology: Astellas Deal Highlights The Platform's Value - Seeking Alpha
Vir Biotechnology: Astellas Deal Highlights The Platform's Value Seeking Alpha
Vir Biotechnology Appoints Aziz Sawaf as New CFO - The Globe and Mail
Vir Biotechnology Appoints Aziz Sawaf as New CFO The Globe and Mail
HC Wainwright & Co. maintains Buy rating on Vir Biotechnology, $22 price target - TradingView
HC Wainwright & Co. maintains Buy rating on Vir Biotechnology, $22 price target TradingView
A finance executive with over 20 years in biopharma is set to join Vir Oct. 5. - Stock Titan
A finance executive with over 20 years in biopharma is set to join Vir Oct. 5. Stock Titan
A medical chief with more than 25 years in cancer drug development is set to join Vir. - Stock Titan
A medical chief with more than 25 years in cancer drug development is set to join Vir. Stock Titan
One talk will cover hepatitis D response data through 96 weeks; another will study liver immune cells. - Stock Titan
One talk will cover hepatitis D response data through 96 weeks; another will study liver immune cells. Stock Titan